Clinical trial
Safety and Efficacy Study of Angiotech Central Venous Catheter to Prevent…
NCT00288418 · Angiotech Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00288418 |
|---|---|
| Title | Safety and Efficacy Study of Angiotech Central Venous Catheter to Prevent Bacterial Catheter Colonization |
| Official title | A Controlled, Randomized, Single-Blind, Multi-Center Pivotal Clinical Study Using Angiotech CVC to Prevent Bacterial Colonization on Short-Term Central Venous Catheters |
| Lead sponsor | Angiotech Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bacterial Infections |
| Intervention type | Device |
| Interventions | Central Venous Catheter |
| Enrollment | 960 |
| Start date | Dec 1, 2005 |
| Primary completion | Jul 1, 2007 |
| Completion | Jul 1, 2007 |
| First posted | Feb 8, 2006 |
| Last update posted | Jan 23, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: